The new Medicare program offers substantial savings on weight-loss medications like Wegovy and Ozempic through December, with ...

*Metabolic and bariatric surgeries in the United States have seen a notable decline in recent years, even as GLP-1 ...

Medicare is launching a temporary GLP-1 Bridge program in July 2026, opening Wegovy and Zepbound access for some retirees.

By HealthDay Staff HealthDay ReporterWEDNESDAY, May 27, 2026 (HealthDay News) — A new study suggests GLP-1 medications may ...

A new study shows oral GLP-1 drugs suppress hedonic eating through a deep-brain reward circuit linked to dopamine release, potentially extending their use beyond weight loss.

It seems like everyone, including public employees, are jumping on the GLP-1 bandwagon. Just as quickly, some of their health ...

Medicare GLP-1 program 6 weeks out introduces new workflows and volume spikes for health systems and pharmacies starting July 1, 2024.

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.

Providers said they are encountering patients seeking treatment for anorexia, bulimia and binge eating disorder who are ...

GLP-1 medications such as Ozempic, Wegovy and Mounjaro have dominated headlines in recent years for their significant ...

A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.

Two of the most common bariatric procedures are gastric sleeve surgery and gastric bypass.